drugset / Trial / NCT07053657

Effect of Vitamin D on Cardiovascular Metabolic Risk in Overweight/Obesity Adolescents in China

NCT07053657

Recruiting 130 enrolled Anhui Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this randomized controlled clinical trial is to investigate the effects of vitamin D3 supplementation on cardiometabolic risk in Chinese adolescents with overweight/obesity and vitamin D deficiency. The main question it aims to answer whether vitamin D3 supplementation can improve cardiovascular metabolic health. Participants in the intervention group will receive vitamin D3. The control group will receive vitamin D placebo. Researchers will compare the change in cardiometabolic risk from baseline to post-intervention at 12 weeks between the intervention and control groups.

Timeline

Start
2025-09-15
Primary completion
2025-12-15
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 800 iu Oral